Increasing Stemness Drives Prostate Cancer Progression, Plasticity, Therapy Resistance and Poor Patient Survival.

Saved in:
Bibliographic Details
Title: Increasing Stemness Drives Prostate Cancer Progression, Plasticity, Therapy Resistance and Poor Patient Survival.
Authors: Liu X; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA., Cortes E; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.; Department of Biostatistics, University at Buffalo, Buffalo, New York, USA., Ji Y; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA., Zhao K; Veracyte Inc, San Diego, California, USA., Ho J; Veracyte Inc, San Diego, California, USA., Liu YS; Veracyte Inc, San Diego, California, USA., Davicioni E; Veracyte Inc, San Diego, California, USA., Feng FY; Department of Radiation Oncology, University of California, San Francisco, California, USA., Alumkal JJ; Department of Hematology and Oncology, Department of Internal Medicine, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA., Spratt DE; University Hospitals Seidman Cancer Center and Case Western Reserve University, Cleveland, Ohio, USA., Sweeney CJ; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, SA 5000, Australia., Yu H; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA., Hu Q; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA., Cheng Z; School of Biomedical Sciences, Hunan University, Changsha, China., Zhang D; School of Biomedical Sciences, Hunan University, Changsha, China., Chatta G; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA., Nastiuk KL; Department of Cancer Genetics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA., Goodrich DW; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA., Rycaj K; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA., Jamroze A; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA., Kirk JS; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA., Puzanov I; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA., Liu S; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA., Wang J; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA., Tang DG; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
Source: BioRxiv : the preprint server for biology [bioRxiv] 2025 Jun 05. Date of Electronic Publication: 2025 Jun 05.
Publication Type: Journal Article; Preprint
Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first